Epigenetic Silencing of TGFBI Confers Resistance to Trastuzumab in Human Breast Cancer. Epigenetic Silencing of TGFBI Confers Resistance to Trastuzumab in Human Breast Cancer
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA509689
下载链接
链接失效反馈官方服务：
资源简介：
Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer. Overall design: Bisulphite-converted DNA from trastuzumab-sensitive and -resistant models were hybridised to the Illumina Infinium 450k Human Methylation BeadChip.
创建时间：
2018-12-12
